Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
As of close of business last night, Relay Therapeutics Inc’s stock clocked out at $3.23, down -1.82% from its previous closing price of $3.29. In other words, the price has decreased by -$1.82 from its previous closing price. On the day, 1.11 million shares were traded.
Ratios:
To gain a deeper understanding of RLAY’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 19.96 and its Current Ratio is at 19.96. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on April 17, 2025, initiated with a Equal Weight rating and assigned the stock a target price of $4.
On September 10, 2024, Jefferies Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $10.60 to $16.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 30 ’25 when Rahmer Peter sold 10,739 shares for $3.00 per share. The transaction valued at 32,217 led to the insider holds 390,081 shares of the business.
Rahmer Peter sold 1,364 shares of RLAY for $4,324 on Apr 28 ’25. The insider now owns 400,820 shares after completing the transaction at $3.17 per share. On Apr 30 ’25, another insider, Catinazzo Thomas, who serves as the Chief Financial Officer of the company, sold 12,943 shares for $3.00 each. As a result, the insider received 38,829 and left with 355,376 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 72.10 while its Price-to-Book (P/B) ratio in mrq is 0.76.
Stock Price History:
Over the past 52 weeks, RLAY has reached a high of $10.72, while it has fallen to a 52-week low of $1.77. The 50-Day Moving Average of the stock is 13.46%, while the 200-Day Moving Average is calculated to be -31.15%.
Shares Statistics:
A total of 170.48M shares are outstanding, with a floating share count of 129.27M. Insiders hold about 24.60% of the company’s shares, while institutions hold 83.57% stake in the company.
